Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
4.500
-0.030 (-0.66%)
At close: Feb 17, 2026, 4:00 PM EST
4.500
0.00 (0.00%)
After-hours: Feb 17, 2026, 4:30 PM EST

Altimmune Revenue

Altimmune had revenue of $5.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $20.00K, down -61.54% year-over-year. In the year 2024, Altimmune had annual revenue of $20.00K, down -95.31%.

Revenue (ttm)
$20.00K
Revenue Growth
-61.54%
P/S Ratio
28,490.17
Revenue / Employee
$339
Employees
59
Market Cap
563.54M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202420.00K-406.00K-95.31%
Dec 31, 2023426.00K494.00K-
Dec 31, 2022-68.00K-4.48M-
Dec 31, 20214.41M-3.78M-46.12%
Dec 31, 20208.19M2.38M41.09%
Dec 31, 20195.80M-4.53M-43.85%
Dec 31, 201810.33M-407.15K-3.79%
Dec 31, 201710.74M7.50M231.82%
Dec 31, 20163.24M-7.40M-69.59%
Dec 31, 201510.64M450.46K4.42%
Dec 31, 201410.19M-7.72M-43.11%
Dec 31, 201317.91M-7.26M-28.85%
Dec 31, 201225.18M909.61K3.75%
Dec 31, 201124.27M3.27M15.59%
Dec 31, 201020.99M-6.56M-23.80%
Dec 31, 200927.55M-5.36M-16.29%
Dec 31, 200832.91M18.27M124.75%
Dec 31, 200714.64M12.98M780.39%
Dec 31, 20061.66M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CorMedix214.30M
Lexicon Pharmaceuticals70.86M
MeiraGTx Holdings27.42M
Prime Medicine5.98M
ProKidney744.00K
Lyell Immunopharma41.00K
Revenue Rankings